Allergan, Inc. (AGN) Tops Q3 EPS by 2c; Guides Q4, FY12 EPS, Revs
Tweet Send to a Friend
Allergan, Inc. (NYSE: AGN) reported Q3 EPS of $1.06, $0.02 better than the analyst estimate of $1.04. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
